Securities code: 300760 securities abbreviation: Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) Announcement No.: 2022-006 Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760)
Announcement on the shareholding of the top ten shareholders and the top ten shareholders with unlimited sales conditions on the repurchase of shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) (hereinafter referred to as “the company” or “the company”) held the 14th meeting of the 7th board of directors on January 13, 2022, deliberated and adopted the proposal on share repurchase scheme of the company. The company plans to use its own funds to repurchase some social public shares of the company in the form of centralized bidding transaction. The shares to be repurchased will be cancelled and the registered capital will be reduced according to law, This proposal needs to be submitted to the general meeting of shareholders of the company for deliberation. For details, please refer to cninfo (www.cn. Info. Com. CN.) published on January 13, 2022 on the gem information disclosure website designated by China Securities Regulatory Commission Announcement on share repurchase scheme of the company on the.
In accordance with the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 9 – share repurchase and other relevant provisions, the names, shareholding quantities and shareholding ratios of the top ten shareholders and the top ten shareholders with unlimited sales conditions registered on the trading day before the board of directors announced the share repurchase resolution (i.e. January 12, 2022) are hereby announced as follows:
1、 The top ten shareholders registered on the trading day before the board of directors announced the share repurchase resolution
No. shareholder name number (shares) in total share capital of the company
1 Smartco Development Li mi ted 327,072,335 26.90%
2 Magnifice（HK）Limited 296,951,000 24.43%
3 Hong Kong Central Clearing Company Limited 107786285 8.87%
4 Ever Union（H.K.）Limited 53,526,377 4.40%
5 Shenzhen Ruilong consulting service partnership (limited partnership) 4114652 3.38%
6 Shenzhen Ruifu management consulting partnership (limited partnership) 38953213 3.20%
7 Shenzhen Ruijia management consulting partnership (limited partnership) 15366730 1.26%
8 Shenzhen Ruixiang investment consulting partnership (limited partnership) 13991238 1.15%
Industrial And Commercial Bank Of China Limited(601398) – Jingshun Great Wall
9. Emerging growth hybrid securities investment fund 12499801 1.03%
Industrial And Commercial Bank Of China Limited(601398) – Central European medical
10. Healthy hybrid securities investment fund 12157660 1.00%
Note: the number of shares held by the above shareholders is the total number of shares held after the combination of general accounts and margin trading credit accounts.
2、 Information on the top ten shareholders with unlimited sales conditions registered on the trading day before the board of directors announced the share repurchase resolution
No. shareholder name number (shares) in total share capital of the company
1 Smartco Development Li mi ted 327,072,335 26.90%
2 Magnifice（HK）Limited 296,951,000 24.43%
3 Hong Kong Central Clearing Company Limited 107786285 8.87%
4 Ever Union（H.K.）Limited 53,526,377 4.40%
5 Shenzhen Ruilong consulting service partnership (limited partnership) 4114652 3.38%
6 Shenzhen Ruifu management consulting partnership (limited partnership) 38953213 3.20%
7 Shenzhen Ruijia management consulting partnership (limited partnership) 15366730 1.26%
8 Shenzhen Ruixiang investment consulting partnership (limited partnership) 13991238 1.15%
Industrial And Commercial Bank Of China Limited(601398) – Jingshun Great Wall
9. Emerging growth hybrid securities investment fund 12499801 1.03%
Industrial And Commercial Bank Of China Limited(601398) – Central European medical
10. Healthy hybrid securities investment fund 12157660 1.00%
Note: the number of shares held by the above shareholders is the total number of shares held after the combination of general accounts and margin trading credit accounts.
It is hereby announced.
Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) board of directors January 19, 2022
